Effect of Paget's disease on survival in breast cancer: An exploratory study

Archives of Surgery

Volumn 146, Issue 11, 2011, Pages 1267-1270

  Ortiz Pagan, Sonia ^a   Cunto Amesty, Gina ^a   Narayan, Sandeep ^a   Crawford, Sybil ^a   Derrick, Chase ^a   Larkin, Anne ^a   Khan, Ashraf ^a   Quinlan, Robert ^a   Layeequr Rahman, Rakhshanda ^a,b  

^a University of Massachusetts   (United States)

^b TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR 2;

ADULT; ARTICLE; BREAST CANCER; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FOLLOW UP; HISTOPATHOLOGY; HORMONAL THERAPY; HUMAN; HUMAN TISSUE; MASTECTOMY; MEDICAL RECORD REVIEW; PAGET NIPPLE DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TREATMENT DURATION;

BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MASSACHUSETTS; MIDDLE AGED; NEOPLASM STAGING; PAGET'S DISEASE, MAMMARY; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SEER PROGRAM; SURVIVAL RATE;

EID: 81855199714     PISSN: 00040010     EISSN: 15383644     Source Type: Journal    
DOI: 10.1001/archsurg.2011.278     Document Type: Article

References (16)

1. Kaelin CM. Paget's disease. In: Harris JR, Lippman ME, Morrow M, Osborne CK, eds. Diseases of the Breast. 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2004:1007-1014.
2. Velpeau A. On Disease of the Mammary Areola Preceding Cancer of the Mammary Region. Mitchel H, trans. London, England: Sydenham Society; 1856.
3. Paget J. On disease of the mammary areola preceding cancer of the mammary gland. St Bartholomews Hosp Res Lond. 1874;10:87-89.
4. Singletary SE, Connolly JL. Breast cancer staging: working with the sixth edition of the AJCC Cancer Staging Manual. CA Cancer J Clin. 2006;56(1):37-47, 50-51.
5. Marshall JK, Griffith KA, Haffty BG, et al. Conservative management of Paget's disease of the breast with radiotherapy: 10-year and 15-year results. Cancer. 2003;97(9):2142-2149. (Pubitemid 36444054)
6. National Cancer Institute. Surveillance Epidemiology and End Results home page. http://www.seer.cancer.gov. Accessed February 24, 2011.
7. Hosmer DW, Lemeshow S, May S. Applied Survival Analysis: Regression Modeling of Time to Event Data. 2nd ed. New York, NY: Wiley; 2008.
8. Lin DY, Wei LJ. The robust inference for the proportional hazards model. J Am Stat Assoc. 1989;84:1074-1078.
9. American Joint Committee on Cancer. Breast. In: AJCC Cancer Staging Manual. 6th ed. New York, NY: Springer; 2002:171-180.
10. American Cancer Society (ACS). Cancer facts and figures. 2006. http://www.cancer.org/Research/CancerFactsFigures/index. Accessed January 7, 2011.
11. National Cancer Institute of Canada (NCIC). Canadian cancer statistics. 2006. NCIC Web site. http://www.ncic.cancer.ca/Canada-wide/About%20cancer/ Cancer%20statistics/~/media/CCS/Canada%20wide/Files%20List/ English%20files%20heading/pdf%20not%20in%20publications%20section/ Canadian%20Cancer%20Statistics%20-%202006%20-%20EN%20-%20PDF-935505792.ashx. Accessed January 7, 2011.
12. Fu W, Lobocki CA, Silberberg BK, Chelladurai M, Young SC. Molecular markers in Paget disease of the breast. J Surg Oncol. 2001;77(3):171-178. (Pubitemid 32645771)
13. Chen CY, Sun LM, Anderson BO. Paget disease of the breast: changing patterns of incidence, clinical presentation, and treatment in the US. Cancer. 2006;107(7):1448-1458. (Pubitemid 44546903)
14. Haerslev T, Krag Jacobsen G. Expression of cytokeratin and erbB-2 oncoprotein in Paget's disease of the nipple: an immunohistochemical study. APMIS. 1992;100(11):1041-1047. (Pubitemid 23012570)
15. Winstanley J, Cooke T, Murray GD, et al. The long term significance of c-erbB-2 in primary breast cancer. Br J Cancer. 1991;63:447-450.
16. Wolber RA, Dupuis BA, Wick MR. Expression of c-erbB-2 oncoprotein in mammary and extramammary Paget's disease. Am J Clin Pathol. 1991;96(2):243-247.